Morocco Pharmaceuticals and Healthcare Report Q4 2011

Research and Markets: Morocco Pharmaceuticals and Healthcare Report Q4 2011

DUBLIN–(BUSINESS WIRE)–Research and Markets(http://www.researchandmarkets.com/research/720092/morocco_pharmaceut) has announced the addition of the “Morocco Pharmaceuticals and Healthcare Report Q4 2011” report to their offering.

“Morocco Pharmaceuticals and Healthcare Report Q4 2011”

Business Monitor International’s Morocco Pharmaceuticals and Healthcare Report provides industry professionals and strategists, corporate analysts, pharmaceutical associations, government departments and regulatory bodies with independent forecasts and competitive intelligence on Morocco’s pharmaceuticals and healthcare industry.

BMI View:

While the depreciation of the local tender will negatively impact market growth in US dollar terms, the roll-out of the insurance scheme and the elevated inflation will continue to push up local currency valuations. BMI envisages that the market will experience a compound annual growth rate (CAGR) of 10.11% between 2010 and 2015, with per-capita expenditure rising to US$67 by the end of this period, which is more than double the current level.

Headline Expenditure Projections:

Pharmaceuticals: MAD8.24bn (US$1.05bn) in 2010 to MAD8.96bn (US$1.04bn) in 2011; +8.7% in local currency terms and -0.6% in US dollar terms. Forecast down slightly from Q311 due to lower historical data and depreciation of the dirham.

Healthcare: MAD43.10bn (US$5.47bn) in 2010 to MAD47.28bn (US$5.49bn) in 2011; +9.7% in local currency terms and +0.3% in US dollar terms. Forecast up slightly from Q311 due to the increase in spending associated with the RAMED scheme.

Medical devices: MAD1.66bn (US$210mn) in 2010 to MAD1.79bn (US$208mn) in 2011; +8.0% in local currency terms and -1.2% in US dollar terms. Forecast down slightly from Q311 due to lower historical data and depreciation of the dirham.

Key Trends & Developments:

In August 2011, the Moroccan Ministry of Health closed 13 hospitals as they were unable to fulfil certain hygienic standards, reported Magharebia.com. The health violations included operating rooms with windows facing gardens, a shortage of oxygen cylinders and usage of nonsterile equipment. Health Minister Yasmina Baddou announced that the clinics would be allowed to reopen if they fulfilled the required hygiene standards.

For more information, including full table of contents and list of companies mentioned, please visithttp://www.researchandmarkets.com/research/720092/morocco_pharmaceut